Stock·NASDAQ·Technology
NVIDIA Corporation (NVDA)
- Market cap
- $5.22T
- P/E
- 27.31
- Dividend yield
- 0.24%
- Street target
- $315.00median of 62 analysts
- 52-week range
- $164.27 $243.37
NVDA stock forecast today
Where NVDA stands today, and what CleaRank Financial AI makes of it.
NVDA at a glance
NVIDIA Corporation (NVDA): Buy, 76/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($203.82 and $222.30).
- Earnings NVDA beat estimates in 8 of its last 8 quarters, yet fell the next day after 5 of those beats.
- Insiders Insiders sold $3.8B and made no open-market purchases over the last 18 months.
- Valuation P/E of 27.3 against 35.1 for the Technology sector: a discount to peers (-22%).
Figures as of October 26, 2026.
CleaRank Financial AI
NVIDIA Corporation (NVDA) earns a CleaRank rating of Buy with a model score of 76/100.
The analysts' outlook lifts the score the most, with 59 of 62 analysts rating the stock a buy and a median target 45.8% above the price. Momentum holds the score back the most, as the MACD line is negative. The trend is mixed: NVDA trades 2.83% below its 50-day average of $222.30 yet sits 5.98% above its 200-day average of $203.82. Across the past year, the price rose 15.97%.
Only on CleaRank
Figures we compute ourselves from NVDA's own price, earnings and insider-filing history. Tap one to see it in context.
NVDA stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $216.00 is 2.8% below the 50-day simple moving average of $222.30.Price above its 200-day average ›
The price is 6.0% above the 200-day simple moving average of $203.82.50-day average above the 200-day ›
The 50-day average ($222.30) is 9.1% above the 200-day average ($203.82), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 65% of its 52-week range, between $164.27 and $243.37.
NVDA share price
Pick a period: each tab shows how far NVDA has moved over it, to the last close.
Today's trading
Where NVDA sits inside today's range and its 52-week range.
NVDA fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 27.31 is 22.2% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 17.22 is 126.5% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $192.9B on revenue of $303.0B, a net margin of 63.7%.Beat estimates in most recent reports ›
NVDA beat the EPS estimate in 8 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 0.24%, or $0.52 a share a year.
Key statistics
The headline figures for NVDA.
As of October 26, 2026, NVDA trades at $216.00, with a market value of $5.22T, a P/E ratio of 27.31 and a dividend yield of 0.24%.
What the numbers say
CleaRank Financial AI's reading of NVDA's valuation, growth and risks.
NVDA is priced at a trailing P/E of 27.31, which is 24.0% below the Technology sector median of 35.1; the peer comparison on this page calls that a discount to peers. On sales the picture differs: the P/S of 17.22 is 126.5% above the sector median of 7.6. The company is valued at $5.22T, and its trailing earnings come to $7.91 per share.
Profitability shows a net margin of 63.66% and an operating margin of 66.24%. It reports a return on equity of 117.21%, above the sector median of 13.4%. It also reports debt-to-equity of 0.17 and a trailing dividend yield of 0.24% ($0.52 a share a year).
NVDA's latest report, dated August 26, 2026, delivered EPS of $2.22, which topped the $2.09 estimate by 6.22%. Investors responded in kind, as the stock climbed 8.74% in the next session.
The record is a clean sweep: 8 beats in 8 reports, though the stock still fell in the first session after 5 of those 8 beats. Earlier, the stock fell 5.46% after the February 25, 2026 report, a beat of 5.19%. The consensus EPS estimate stands at $9.31 for this fiscal year and $15.91 for next, growth of 95.2% for the current year.
Normal swings for NVDA run at about 1.75% a day; measured against the S&P 500, its beta is 2.22. Over the last 18 months, insider sales totalled $3.8B with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
NVDA against the Technology sector
How NVDA compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: NVDA trades at a notable discount to sector peers (-22%), which may indicate undervaluation or specific company headwinds.
Return vs XLK: Since May 14, 2025, NVDA has gained 59.6% against a gain of 59.2% for XLK.
Performance against XLK
NVDA and the Technology sector fund over the same days.
Revenue and earnings
How much NVDA sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to April 30, 2026); NVDA reported again on August 26, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 65.5% in FY2026 to $216B, from $130B a year earlier.
Profit margin: The net margin was 55.6% in FY2026, down from 55.8% the year before.
Profitable: NVDA earned $120B in FY2026.
Earnings reality check
Did NVDA beat what analysts expected, and how did the stock react?
Earnings record: NVDA beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 5 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 26, 2026after close | $2.09 | $2.22 | +6.22% | +8.74% | +7.04% |
| May 20, 2026after close | $1.77 | $1.87 | +5.65% | -1.77% | -4.13% |
| Feb 25, 2026after close | $1.54 | $1.62 | +5.19% | -5.46% | -6.40% |
| Nov 19, 2025after close | $1.26 | $1.30 | +3.17% | -3.15% | -3.36% |
| Aug 27, 2025after close | $1.01 | $1.05 | +3.96% | -0.79% | -5.47% |
| May 28, 2025after close | $0.75 | $0.81 | +8.00% | +3.25% | +5.27% |
| Feb 26, 2025after close | $0.85 | $0.89 | +4.71% | -8.48% | -10.65% |
| Nov 20, 2024after close | $0.75 | $0.81 | +8.00% | +0.53% | -7.23% |
As of October 26, 2026, NVDA has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 5 of those beats; its latest report, on August 26, 2026, came in 6.22% above the estimate and the stock moved +8.74% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
NVDA AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 44.1, in neutral territory.RSI above 50 ›
An RSI of 44.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of NVDA
The score, the reasoning behind it, and what could move the price next.
NVIDIA Corporation (NVDA) is caught between its two moving averages. The price of $216.00 stands 5.98% above the 200-day average of $203.82, yet 2.83% below the 50-day average of $222.30. That 50-day average sits 9.07% above the 200-day one, and that gap would shrink if the price keeps trading under the shorter average. Within its 52-week range, running from $164.27 to $243.37, the price sits at 65%.
A recent pullback sits inside a stronger longer record: the price fell 4.03% over the past month, rose 9.92% over the past three months and rose 15.97% over the past year. On momentum, the 14-day RSI reads 44.1, in the neutral zone, with the MACD line negative.
Earnings beat ›
The August 26, 2026 report beat the EPS estimate by 6.22%, and the share price rose 8.74% in the first session after it.
Source: Earnings report, August 26, 2026New analyst coverage ›
Piper Sandler started coverage at Overweight on September 10, 2026.
Source: Analyst action, Piper Sandler, September 10, 2026Rating reaffirmed ›
Needham kept its Buy rating on October 22, 2026.
Source: Analyst action, Needham, October 22, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $221.03, which sits above the price, and the 200-day SMA at $203.82, which sits below it.
- The 14-day RSI reads 44.1, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- NVDA beat estimates in 8 of the last 8 reports, and after the August 26, 2026 report the share price climbed 8.74% in the first session.
NVDA sits in a mixed trend. The price is above its 200-day average of $203.82 but below its 50-day average of $222.30. A close above the 50-day would turn both signals higher, while a close below the 200-day would turn both lower. For now, the price is held between the 200-day SMA at $203.82 underneath and the 20-day EMA at $221.03 overhead.
The 14-day RSI of 44.1 is in the neutral band, between 40 and 60.
Technical indicators
Momentum and trend for NVDA, from its daily closes.
As of October 26, 2026, with NVDA at $216.00, its 14-day RSI is 44.1 (neutral territory), its 50-day simple moving average is $222.30 and its 200-day is $203.82.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What NVDA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, NVDA's 1-year correlation of daily returns is +0.69 with S&P 500 (SPY), +0.74 with Nasdaq 100 (QQQ), +0.36 with Bitcoin (BTC) and +0.12 with gold (XAU).
NVDA price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
59 of 62 analysts rate it a buy or strong buy, 2 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $315.00 is 45.8% above the price.More buy ratings than three months ago ›
59 of 62 rate it a buy now, against 58 of 61 three months ago.
NVDA Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 22, 2026 | Needham | Reiterates | Buy |
| Oct 1, 2026 | Cantor Fitzgerald | Reiterates | Overweight |
| Sep 29, 2026 | Rosenblatt | Maintains | Buy |
| Sep 10, 2026 | Piper Sandler | Initiates | Overweight |
| Sep 4, 2026 | Rosenblatt | Maintains | Buy |
| Sep 4, 2026 | Needham | Reiterates | Buy |
As of October 26, 2026, 62 Wall Street analysts cover NVDA: 59 rate it a buy or strong buy, 2 a hold and 1 a sell or strong sell. Their 12-month price targets range from $180.00 to $515.00. The median NVDA price target is $315.00, 45.8% above the price of $216.00.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
NVDA trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NVDA trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NVDA's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NVDA tends to move, against the market and on its own.
NVDA price history and drawdowns
NVDA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.75% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 64.1%, from November 2021 to October 2022, regained by May 2023.Most 1-year holds ended higher ›
81% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $1,245,703, against $42,015 in the S&P 500 (SPY).
NVDA Drawdowns & Recovery
As of October 26, 2026, NVDA's worst peak-to-trough fall over the last 10 years with dividends reinvested was -64.1% (November 2021 to October 2022); it regained that peak by May 2023, 7 months after the low, and 81% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NVDA in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NVDA beat the S&P 500 over this period: $1,245,703 against $42,015.
A $10,000 investment in NVDA in October 2016 would be worth about $1,245,703 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NVDA, and which have not.
Strongest month, May: an average of +12.11%, up in 8 of 10 years.
Weakest month, September: an average of -2.74%, up in 3 of 10 years.
This month, October: has averaged +4.68%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NVDA's strongest calendar month has been May (average +12.11%, up in 8 of 10 years) and its weakest September (average -2.74%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
NVDA stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NVDA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in NVDA today could grow to about $15,716 by 2030 in the base case, with a 90th-percentile outcome near $56,325 and a 10th-percentile outcome around $4,385. The simulation models price only; at today's 0.24% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NVDA Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $339 for NVDA by 2030 in the base case, from $216 today (1.6x over 4 years). The 10th-percentile path ends near $94.71. These are outcomes of a Monte Carlo simulation run on NVDA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $128 | $242 | $458 | |
| 2028 | $110 | $271 | $668 | |
| 2029 | $100 | $303 | $916 | |
| 2030 | $94.71 | $339 | $1,217 |
Method: a lognormal simulation of NVDA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. NVDA is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
NVDA insider trading
What the people running the company have bought and sold.
NVDA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought NVDA shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, NVDA insiders reported 86 open-market sales worth $3.8B and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Timothy S Teter
General Counsel
|
Sell | 30.5K | $6.8M |
| Sep 18, 2026 | Mark A Stevens
Director
|
Sell | 1.4M | $300.1M |
| Sep 9, 2026 | Nicholas P Parker
Officer
|
Grant | 172.5K | - |
| Sep 9, 2026 | Nicholas P Parker
Officer
|
Grant | 160.4K | - |
| Sep 4, 2026 | Mark A Stevens
Director
|
Sell | 1.0M | $235.6M |
| Sep 2, 2026 | Mark A Stevens
Director
|
Sell | 1.8M | $410.8M |
| Sep 2, 2026 | Tench C Coxe
Director
|
Grant | 500.0K | - |
| Aug 31, 2026 | Timothy S Teter
General Counsel
|
Sell | 30.0K | $6.5M |
| Aug 10, 2026 | Johnson Suzanne M Nora
Director
|
Grant | 2.4K | - |
| Aug 5, 2026 | Tench C Coxe
Director
|
Grant | 500.0K | - |
| Jul 1, 2026 | Tench C Coxe
Director
|
Grant | 500.0K | - |
| Jun 25, 2026 | Tench C Coxe
Director
|
Grant | 1.2K | - |
| Jun 25, 2026 | John O Dabiri
Director
|
Grant | 1.2K | - |
| Jun 25, 2026 | Beach Dawn E Hudson
Director
|
Grant | 1.2K | - |
| Jun 25, 2026 | Harvey C Jones Jr.
Director
|
Grant | 1.2K | - |
| Jun 25, 2026 | Melissa Lora
Director
|
Grant | 1.2K | - |
| Jun 25, 2026 | Stephen C. Neal
Director
|
Grant | 1.2K | - |
| Jun 25, 2026 | A Brooke Seawell
Director
|
Grant | 1.2K | - |
| Jun 25, 2026 | Aarti S Shah
Director
|
Grant | 1.2K | - |
| Jun 25, 2026 | Mark A Stevens
Director
|
Grant | 1.2K | - |
| Jun 18, 2026 | Mark A Stevens
Director
|
Sell | 885.0K | $186.0M |
| Jun 16, 2026 | Jen-Hsun Huang
Chief Executive Officer
|
Grant | 400.0K | - |
| Jun 8, 2026 | Scott Gawel
Officer
|
Grant | 59.5K | - |
| Jun 4, 2026 | Mark A Stevens
Director
|
Sell | 1.0M | $221.1M |
| Jun 4, 2026 | Mark A Stevens
Director
|
Grant | 307.5K | - |
| Jun 3, 2026 | Stephen C. Neal
Director
|
Sell | 15.5K | $3.3M |
| May 27, 2026 | John O Dabiri
Director
|
Sell | 625 | $133.8K |
| Mar 20, 2026 | Mark A Stevens
Director
|
Sell | 221.7K | $38.5M |
| Mar 20, 2026 | Colette M. Kress
Chief Financial Officer
|
Sell | 62.7K | $11.0M |
| Mar 20, 2026 | Donald F Robertson Jr
Officer
|
Sell | 5.4K | $942.9K |
| Mar 19, 2026 | Aarti S Shah
Director
|
Sell | 19.0K | $3.4M |
| Mar 18, 2026 | Ajay K Puri
Officer
|
Sell | 300.0K | $54.7M |
| Mar 18, 2026 | Jen-Hsun Huang
Chief Executive Officer
|
Grant | 59.0M | - |
| Mar 17, 2026 | A Brooke Seawell
Director
|
Grant | 530 | - |
| Mar 13, 2026 | John O Dabiri
Director
|
Sell | 3.0K | $555.4K |
| Mar 10, 2026 | Ajay K Puri
Officer
|
Sell | 300.0K | $54.8M |
| Mar 9, 2026 | Colette M. Kress
Chief Financial Officer
|
Grant | 47.0K | - |
| Mar 9, 2026 | Ajay K Puri
Officer
|
Grant | 47.0K | - |
| Mar 9, 2026 | Debora C Shoquist
Officer
|
Grant | 47.0K | - |
| Mar 9, 2026 | Timothy S Teter
General Counsel
|
Grant | 47.0K | - |
| Mar 2, 2026 | Jen-Hsun Huang
Chief Executive Officer
|
Grant | 936.8K | - |
| Mar 2, 2026 | Colette M. Kress
Chief Financial Officer
|
Grant | 106.7K | - |
| Mar 2, 2026 | Ajay K Puri
Officer
|
Grant | 103.3K | - |
| Mar 2, 2026 | Debora C Shoquist
Officer
|
Grant | 98.3K | - |
| Mar 2, 2026 | Timothy S Teter
General Counsel
|
Grant | 98.3K | - |
| Feb 4, 2026 | Colette M. Kress
Chief Financial Officer
|
Sell | 47.6K | $8.4M |
| Jan 21, 2026 | Ajay K Puri
Officer
|
Sell | 200.0K | $36.0M |
| Jan 13, 2026 | Colette M. Kress
Chief Financial Officer
|
Sell | 47.6K | $8.8M |
| Jan 7, 2026 | Ajay K Puri
Officer
|
Sell | 200.0K | $37.6M |
| Jan 2, 2026 | Donald F Robertson Jr
Officer
|
Sell | 80.0K | $15.2M |
| Dec 19, 2025 | Mark A Stevens
Director
|
Sell | 222.5K | $40.1M |
| Dec 19, 2025 | Donald F Robertson Jr
Officer
|
Sell | 24.6K | $4.4M |
| Dec 18, 2025 | Mark A Stevens
Director
|
Grant | 258.7K | - |
| Dec 17, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Grant | 141.5K | - |
| Dec 17, 2025 | Colette M. Kress
Chief Financial Officer
|
Grant | 113.2K | - |
| Dec 15, 2025 | Harvey C Jones Jr.
Director
|
Sell | 250.0K | $44.3M |
| Dec 12, 2025 | Debora C Shoquist
Officer
|
Sell | 229.8K | $41.4M |
| Dec 12, 2025 | Colette M. Kress
Chief Financial Officer
|
Sell | 50.5K | $9.0M |
| Dec 9, 2025 | Debora C Shoquist
Officer
|
Sell | 80.0K | $14.8M |
| Dec 5, 2025 | Mark A Stevens
Director
|
Sell | 350.0K | $63.6M |
| Dec 2, 2025 | A Brooke Seawell
Director
|
Sell | 12.7K | $2.3M |
| Nov 24, 2025 | John O Dabiri
Director
|
Sell | 626 | $112.3K |
| Nov 24, 2025 | A Brooke Seawell
Director
|
Grant | 520.0K | - |
| Nov 3, 2025 | Colette M. Kress
Chief Financial Officer
|
Sell | 47.6K | $9.9M |
| Oct 29, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 25.0K | $5.2M |
| Oct 28, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 125.0K | $23.6M |
| Oct 23, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $40.7M |
| Oct 21, 2025 | Colette M. Kress
Chief Financial Officer
|
Sell | 47.6K | $8.6M |
| Oct 20, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $41.1M |
| Oct 15, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $41.3M |
| Oct 10, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $42.9M |
| Oct 7, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $42.1M |
| Oct 2, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $42.1M |
| Sep 29, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $40.2M |
| Sep 24, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $40.2M |
| Sep 19, 2025 | Mark A Stevens
Director
|
Sell | 350.0K | $61.7M |
| Sep 19, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $39.2M |
| Sep 19, 2025 | Colette M. Kress
Chief Financial Officer
|
Sell | 50.5K | $8.9M |
| Sep 19, 2025 | Persis S Drell
Director
|
Sell | 40.0K | $7.1M |
| Sep 19, 2025 | Donald F Robertson Jr
Officer
|
Sell | 3.5K | $617.3K |
| Sep 18, 2025 | Harvey C Jones Jr.
Director
|
Sell | 250.0K | $44.1M |
| Sep 16, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $39.7M |
| Sep 15, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Grant | 1.1M | - |
| Sep 12, 2025 | Mark A Stevens
Director
|
Sell | 497.8K | $88.6M |
| Sep 12, 2025 | Stephen C. Neal
Director
|
Sell | 28.0K | $5.0M |
| Sep 11, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $39.3M |
| Sep 8, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $38.0M |
| Sep 8, 2025 | Tench C Coxe
Director
|
Grant | 1.0M | - |
| Sep 3, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $38.6M |
| Sep 3, 2025 | Beach Dawn E Hudson
Director
|
Sell | 90.0K | $15.4M |
| Aug 29, 2025 | Stephen C. Neal
Director
|
Grant | 1.7K | - |
| Aug 29, 2025 | A Brooke Seawell
Director
|
Grant | 1.2M | - |
| Aug 29, 2025 | Debora C Shoquist
Officer
|
Grant | 55.2K | - |
| Aug 15, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 150.0K | $27.1M |
| Aug 13, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $41.0M |
| Aug 8, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $40.7M |
| Aug 5, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $39.8M |
| Aug 4, 2025 | Colette M. Kress
Chief Financial Officer
|
Sell | 47.6K | $8.5M |
| Jul 31, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $40.2M |
| Jul 28, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $39.2M |
| Jul 23, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $38.2M |
| Jul 18, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $38.7M |
| Jul 15, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $37.6M |
| Jul 15, 2025 | Colette M. Kress
Chief Financial Officer
|
Sell | 47.7K | $8.1M |
| Jul 14, 2025 | A Brooke Seawell
Director
|
Sell | 96.9K | $16.0M |
| Jul 10, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $36.4M |
| Jul 10, 2025 | A Brooke Seawell
Director
|
Sell | 148.4K | $24.0M |
| Jul 7, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $35.6M |
| Jul 7, 2025 | A Brooke Seawell
Director
|
Sell | 101.9K | $16.0M |
| Jul 1, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 225.0K | $35.2M |
| Jul 1, 2025 | A Brooke Seawell
Director
|
Sell | 102.7K | $16.0M |
| Jun 27, 2025 | A Brooke Seawell
Director
|
Sell | 155.2K | $24.0M |
| Jun 26, 2025 | Jen-Hsun Huang
Chief Executive Officer
|
Sell | 200.0K | $30.5M |
| Jun 26, 2025 | Robert Kenneth Burgess
Director
|
Grant | 1.8K | - |
| Jun 26, 2025 | Tench C Coxe
Director
|
Grant | 1.8K | - |
| Jun 26, 2025 | John O Dabiri
Director
|
Grant | 1.8K | - |
| Jun 26, 2025 | Persis S Drell
Director
|
Grant | 1.8K | - |
| Jun 26, 2025 | Beach Dawn E Hudson
Director
|
Grant | 1.8K | - |
| Jun 26, 2025 | Harvey C Jones Jr.
Director
|
Grant | 1.8K | - |
| Jun 26, 2025 | Melissa Lora
Director
|
Grant | 1.8K | - |
Source: TwelveData, from SEC Form 4 filings
NVDA stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.